Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $1.60 billion. The enterprise value is $1.63 billion.
Important Dates
The last earnings date was Tuesday, February 24, 2026, before market open.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 51.20 million shares outstanding. The number of shares has increased by 4.05% in one year.
| Current Share Class | 51.20M |
| Shares Outstanding | 51.20M |
| Shares Change (YoY) | +4.05% |
| Shares Change (QoQ) | -5.30% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 84.61% |
| Float | 49.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.10 |
| Forward PS | 6.08 |
| PB Ratio | 11.44 |
| P/TBV Ratio | 13.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 1,968.54 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.11, with a Debt / Equity ratio of 0.56.
| Current Ratio | 5.11 |
| Quick Ratio | 2.87 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | 29.53 |
| Debt / FCF | n/a |
| Interest Coverage | -1.02 |
Financial Efficiency
Return on equity (ROE) is -13.49% and return on invested capital (ROIC) is -2.61%.
| Return on Equity (ROE) | -13.49% |
| Return on Assets (ROA) | -2.31% |
| Return on Invested Capital (ROIC) | -2.61% |
| Return on Capital Employed (ROCE) | -3.96% |
| Weighted Average Cost of Capital (WACC) | 9.51% |
| Revenue Per Employee | $498,248 |
| Profits Per Employee | -$34,741 |
| Employee Count | 452 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.35% in the last 52 weeks. The beta is 0.96, so Axogen's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +73.35% |
| 50-Day Moving Average | 32.93 |
| 200-Day Moving Average | 20.55 |
| Relative Strength Index (RSI) | 39.37 |
| Average Volume (20 Days) | 987,199 |
Short Selling Information
The latest short interest is 2.75 million, so 5.38% of the outstanding shares have been sold short.
| Short Interest | 2.75M |
| Short Previous Month | 2.85M |
| Short % of Shares Out | 5.38% |
| Short % of Float | 5.60% |
| Short Ratio (days to cover) | 2.71 |
Income Statement
In the last 12 months, Axogen had revenue of $225.21 million and -$15.70 million in losses. Loss per share was -$0.34.
| Revenue | 225.21M |
| Gross Profit | 167.35M |
| Operating Income | -7.85M |
| Pretax Income | -15.70M |
| Net Income | -15.70M |
| EBITDA | -874,000 |
| EBIT | -7.85M |
| Loss Per Share | -$0.34 |
Full Income StatementBalance Sheet
The company has $41.53 million in cash and $71.52 million in debt, with a net cash position of -$29.99 million or -$0.59 per share.
| Cash & Cash Equivalents | 41.53M |
| Total Debt | 71.52M |
| Net Cash | -29.99M |
| Net Cash Per Share | -$0.59 |
| Equity (Book Value) | 128.85M |
| Book Value Per Share | 2.73 |
| Working Capital | 96.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $812,000 and capital expenditures -$3.75 million, giving a free cash flow of -$2.93 million.
| Operating Cash Flow | 812,000 |
| Capital Expenditures | -3.75M |
| Free Cash Flow | -2.93M |
| FCF Per Share | -$0.06 |
Full Cash Flow StatementMargins
Gross margin is 74.31%, with operating and profit margins of -3.49% and -6.97%.
| Gross Margin | 74.31% |
| Operating Margin | -3.49% |
| Pretax Margin | -6.97% |
| Profit Margin | -6.97% |
| EBITDA Margin | -0.39% |
| EBIT Margin | -3.49% |
| FCF Margin | n/a |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.05% |
| Shareholder Yield | -4.05% |
| Earnings Yield | -0.98% |
| FCF Yield | -0.18% |
Analyst Forecast
The average price target for Axogen is $35.10, which is 12.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.10 |
| Price Target Difference | 12.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 17.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 4.64 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.64 |
| Piotroski F-Score | 4 |
